Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / ADR
-
Number of holders
-
756
-
Total 13F shares, excl. options
-
208,541,052
-
Shares change
-
+1,560,555
-
Total reported value, excl. options
-
$8,032,573,648
-
Value change
-
+$51,491,334
-
Put/Call ratio
-
96%
-
Number of buys
-
263
-
Number of sells
-
-399
-
Price
-
$38.51
Significant Holders of GLAXOSMITHKLINE PLC - ADR (GSK) as of Q4 2016
860 filings reported holding GSK - GLAXOSMITHKLINE PLC - ADR as of Q4 2016.
GLAXOSMITHKLINE PLC - ADR (GSK) has 756 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 208,541,052 shares
.
Largest 10 shareholders include FMR LLC (21,153,029 shares), Fisher Asset Management, LLC (11,809,500 shares), STATE STREET CORP (10,600,829 shares), PRICE T ROWE ASSOCIATES INC /MD/ (10,392,844 shares), WELLS FARGO & COMPANY/MN (10,050,002 shares), ROYAL BANK OF CANADA (8,414,889 shares), HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC (7,807,200 shares), Bank of New York Mellon Corp (6,007,262 shares), BANK OF AMERICA CORP /DE/ (5,914,704 shares), and MORGAN STANLEY (4,614,293 shares).
This table shows the top 756 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.